Influenza Vaccine

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

Clinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Clinical Trial of Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and Older

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

Efficacy and Safety of Influenza Vaccine During Sarcoidosis

Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Cost-effectiveness of the Influenza Vaccination

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination

Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients

A Phase 2 Study to Evaluate Immune Responses of FluMist®

Influenza 2020/2021

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour

Influenza Vaccine in Children With Asthma